Toronto Raptors president tests positive for covid-19
Though vaccinated, Massai Ujiri will now have to isloate as he recovers.
It seems Ontario's team could be the latest to be plagued by covid-19.
Masai Ujiri tests positive for covid-19
Following his attendance at a gala on Sunday night, the Toronto Raptors' President Masai Ujiri has tested positive for covid-19. While there were initial concerns, Ujiri gave a statement saying that the event itself was held "in compliance with all current public health guidance.” He also went to add that everyone who was present was required to show proof of vaccination as well as wear masks if not eating or drinking.
“Unfortunately, after the gala, we learned of positive covid-19 tests among our guests, and even though I am fully vaccinated and have received a booster shot, I also subsequently tested positive,” he said on Thursday night. Speaking on the developing situation Ujiri stated, “I am now at home, observing the safety protocols by self-isolating for 10 days, monitoring for symptoms and undergoing testing, and I encourage everyone who attended the game to please do the same. We don’t want to live in fear of this virus but COVID is a persistent enemy.”
What event did Masai Ujiri attend
On Sunday night Ujiri was present for the Giants of Africa event. It was the first time since 2019 that it was being held. Giants of Africa is a non-profit youth basketball organization founded by Ujiri and on December 4th and 5th played host to Toronto-based events that were held in honor of late Nelson Mandela's centenary. According to the team's social media coverage.
For more from the NBA
The Toronto Raptors themselves were also in attendance. Team training was subsequently canceled on Thursday as a result of the league's covid-19 health and safety protocols. “The decision was made out of an abundance of caution, and further updates will be provided when necessary,” the team said. It is not clear how many people attended the event or how many of them have returned positive tests for covid-19.